Skip to main content
. 2017 Dec 14;9(4):4814–4822. doi: 10.18632/oncotarget.23307

Table 4. Univariate and multivariate analysis of training set and validation.

Variable Univariate analysis Multivariate analysis
Pa value Hazard ratio(95% CI) P valuea Hazard ratio (95% CI)
Training set
7th AJCC stage (ref: I) <0.001 2.598 (2.256, 2.991) <0.001
 II 0.003 3.810 (1.573, 9.232)
 III <0.001 12.926 (5.699, 29.318)
 IV <0.001 24.239 (10.624, 55.301)
Differentiated type 0.009 1.376 (1.084, 1.748) 0.042 1.284 (1.009, 1.635)
Risk score <0.001 2.082 (1.673, 2.592) 0.015 1.323 (1.056, 1.658)
Validation set
7th AJCC stage (ref: I) <0.001 2.598 (2.256, 2.991) <0.001
 II 0.003 3.466 (1.527, 7.869)
 III <0.001 9.610 (4.472, 20.649)
 IV <0.001 19.974 (9.271, 43.0.32)
Location (ref: Lower) <0.001 2.535 (2.203, 2.917) 0.004
 Upper 0.027 1.369 (1.036, 1.809)
 Middle 0.470 0.895 (0.662, 1.209)
Age 0.001 1.486 (1.181, 1.869) 0.001 1.498 (1.185, 1.892)
Risk score <0.001 2.417 (1.933, 3.023) 0.001 1.446 (1.160, 1.852)

AJCC, American Joint Committee on Cancer.

a Cox proportional hazards model.